Ophthalmology Times Newsletter

To view this email as a web page, click here.

Controlling adult glaucoma with cataract surgery, stent

As the second-leading cause of blindness worldwide, more than 3 million Americans suffer from glaucoma. A new procedure aims to relieve the mechanism and symptoms of the disease and help prevent blindness.

Find out more

New IOL design trends avoid negative dysphotopsias

Newer lab studies reveal increased posterior chamber depth does not cause ND and that any IOL, irrespective of material or edge design, implanted in the capsule bag can result in ND, which resolves when the very same inciting lens is moved from the bag to the ciliary sulcus.

Learn more

Examining comparable surgical methods for IOL dislocation

A complication of implantation of an intraocular lens (IOL) in the capsular bag is its dislocation, which can happen years after an uncomplicated cataract surgery. The average time between IOL implantation and dislocation is 7 to 10 years. The notable culprits that are involved in IOL dislocation are pseudoexfoliation, high myopia, and previous vitrectomy.

Read on

Glaucoma 360 New Horizons Forum in San Francisco

Register to join us at the Grand Hyatt in San Francisco’s Union Square for the 9th Annual New Horizons Forum: speeding the development of new therapies and diagnostics for glaucoma patients.

Learn more.

Intraoperative surgical methods key to AMD treatment

Treating dry eye with recombinant human nerve growth factor

Gene therapy for LHON: Deciphering phase III data

Budding technology could be an OCT analysis game-changer

Weigh risk, benefits of cataract surgery for your patients

Teleglaucoma lets patients be more engaged in care

Safety key for intracamerally injected mydriatic agents in cataract surgery

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.